The integration of multiple biomarkers with high stage-specificity and histological type specificity, including SHOX2 and PTGER4 DNA methylation as well as IDH1, demonstrated superior diagnostic performance in the detection of lung cancers compared to single-marker assessments (sensitivity=86.1% and specificity = 80.0%) (53). This evidence concerns the gene SHOX2 and lung carcinoma.